Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Prescient Medicine CEO Keri Donaldson to Participate in US News & World Report's Panel on Opioid Crisis

Prescient Medicine
Posted on: 01 Nov 17
Prescient Medicine CEO Keri Donaldson to Participate in US News & World Report's Panel on Opioid Crisis Sponsorship of "Healthcare of Tomorrow" Leadership Forum Helps Drive Conversation Around Solutions

PR Newswire

HUMMELSTOWN, Pa., Nov. 1, 2017

HUMMELSTOWN, Pa., Nov. 1, 2017 /PRNewswire/ -- Prescient Medicine, a Pennsylvania-based predictive health intelligence company, will sponsor the 5th Annual U.S. News & World Report Healthcare of Tomorrow leadership forum, taking place in Washington, DC on November 1-3, 2017. Founder and CEO, Keri Donaldson, MD, will participate as part of the "Taking Action to Address the Opioid Crisis" panel discussion on Friday, November 3rd at 8:45 a.m. E.T.

"With the opioid crisis now declared a public health emergency by the U.S. government, it's critical that we work together to help find effective solutions in the form of preventive strategies and predictive insights," said Dr. Donaldson. "We look forward to engaging other leaders to help define and accelerate more immediate and lasting approaches to our nation's most pressing healthcare challenge –the opioid epidemic."

With more than 59,000 opioid-related drug overdoses in 2016 alone, the U.S. opioid crisis highlights an urgent need to improve prescribing guidelines, reduce opioid exposure among at-risk populations, and ensure safe and effective treatments for those who need them. Dr. Donaldson and panelists will examine how providers and policymakers are responding to the crisis and what promising approaches are emerging to combat it.

About   the   Opioid   Epidemic
Opioid abuse is a serious public health issue and drug overdose deaths are the leading cause of injury death in the United States. Accordingly, the economic and societal costs of opioid abuse are impacting millions of American lives every day.

Nationwide, opioid-related hospitalizations cost about $20 billion annually. Societal costs for opioids – including social services, public safety, and criminal justice – will be about $83 billion in 2017. Nearly one-quarter of that economic burden is paid by public, tax-funded sources.

And it's only getting worse. The U.S. is the world leader in opioid prescriptions and it's estimated that as many as 650,000 people will die over the next 10 years from opioid overdoses – more than the entire city of Baltimore. That means that the U.S. risks losing the equivalent of a whole American city in just one decade.

About Prescient Medicine
Prescient Medicine is focused on providing tools that advance the precision healthcare movement. Our powerful tests and analytic solutions offer deeper predictive insights so doctors and patients have the data they need to make better, more informed clinical decisions, leading to the best possible patient outcomes. Laser-focused on solutions that are designed to help combat the opioid epidemic, our key tools include ToxKit®, an advanced drug screening tool, and LifeKit® Prescript, a genetic test that goes beyond pharmacogenomics to evaluate potential drug-to-drug interactions. Our lead solution, LifeKit® Predict, is a validated genetic test designed to predict individual risk of opioid addiction. Prescient has locations in Pennsylvania, Illinois, Kentucky, and Missouri. Visit us at

View original content:

SOURCE Prescient Medicine

PR Newswire

Last updated on: 01/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.